{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:01:36Z","timestamp":1780394496505,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jvir.2024.10.021","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T05:47:59Z","timestamp":1730094479000},"page":"282-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Resin-Based Yttrium-90 Radioembolization as a Bridging or Downstaging Treatment to Liver Transplantation for Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9610-280X","authenticated-orcid":false,"given":"Lawrence","family":"Bonne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6080-1577","authenticated-orcid":false,"given":"Christophe M.","family":"Deroose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3857-466X","authenticated-orcid":false,"given":"Chris","family":"Verslype","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diethard","family":"Monbaliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Dekervel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1950-5581","authenticated-orcid":false,"given":"Charlotte","family":"Van Laeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Vandecaveye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1371-442X","authenticated-orcid":false,"given":"Annouschka","family":"Laenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Pirenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Maleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2024.10.021_bib1","doi-asserted-by":"crossref","first-page":"iv238","DOI":"10.1093\/annonc\/mdy308","article-title":"Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Vogel","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jvir.2024.10.021_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jvir.2024.10.021_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jhep.2012.09.021","article-title":"Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate","volume":"58","author":"Cescon","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jvir.2024.10.021_bib4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1600-6143.2007.02138.x","article-title":"A\u00a0novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria","volume":"8","author":"Volk","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jvir.2024.10.021_bib5","first-page":"1014","article-title":"Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: where do we stand with tumor down-staging?","volume":"63","author":"Yao","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2024.10.021_bib6","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.cgh.2022.02.018","article-title":"UNOS Down-staging criteria for liver transplantation of hepatocellular carcinoma: systematic review and meta-analysis of 25 studies","volume":"21","author":"Tan","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jvir.2024.10.021_bib7","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/j.gastro.2021.07.033","article-title":"Downstaging outcomes for hepatocellular carcinoma: results from the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium","volume":"161","author":"Mehta","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2024.10.021_bib8","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1053\/j.gastro.2016.08.029","article-title":"Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma","volume":"151","author":"Salem","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2024.10.021_bib9","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.31318","article-title":"Liver transplantation following yttrium-90 radioembolization: 15-year experience in 207-patient cohort","volume":"73","author":"Gabr","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2024.10.021_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40001-022-00708-w","article-title":"Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization","volume":"27","author":"Benk\u00f6","year":"2022","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jvir.2024.10.021_bib11","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1007\/s11605-021-05095-x","article-title":"Review of use of Y90 as a bridge to liver resection and transplantation in hepatocellular carcinoma","volume":"25","author":"Qadan","year":"2021","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.jvir.2024.10.021_bib12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s00259-020-04976-8","article-title":"Correlation of Y90-absorbed radiation dose to pathological necrosis in hepatocellular carcinoma: confirmatory multicenter analysis in 45 explants","volume":"48","author":"Gabr","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jvir.2024.10.021_bib13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jvir.2020.12.019","article-title":"Pathologic response of hepatocellular carcinoma treated with yttrium-90 glass microsphere radiation segmentectomy prior to liver transplantation: a validation study","volume":"32","author":"Toskich","year":"2021","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.10.021_bib14","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1007\/s00259-022-05776-y","article-title":"Hepatocellular carcinoma radiation segmentectomy treatment intensification prior to liver transplantation increases rates of complete pathologic necrosis: an explant analysis of 75 tumors","volume":"49","author":"Montazeri","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jvir.2024.10.021_bib15","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s00261-017-1354-6","article-title":"Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinoma","volume":"43","author":"Ahmed","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jvir.2024.10.021_bib16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/SLA.0000000000003253","article-title":"Pathologic response to pretransplant locoregional therapy is predictive of patient outcome after liver transplantation for hepatocellular carcinoma: analysis from the US Multicenter HCC Transplant Consortium","volume":"271","author":"DiNorcia","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvir.2024.10.021_bib17","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/hep.31819","article-title":"Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY Study","volume":"74","author":"Salem","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2024.10.021_bib18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/cancers15030733","article-title":"Liver resection and transplantation following yttrium-90 radioembolization for primary malignant liver tumors: a 15-year single-center experience","volume":"15","author":"Aliseda","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jvir.2024.10.021_bib19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/cancers16010235","article-title":"Transarterial radioembolization (TARE) in patients with hepatocellular carcinoma: a comparison of palliative with bridging-to-transplant concepts","volume":"16","author":"Sch\u00f6nherr","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jvir.2024.10.021_bib20","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.3390\/cancers15072122","article-title":"Selecting the appropriate downstaging and bridging therapies for hepatocellular carcinoma: what is the role of transarterial radioembolization? A pooled analysis","volume":"15","author":"Lopez-Lopez","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jvir.2024.10.021_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.21037\/jgo.2019.06.01","article-title":"Downstaging unresectable hepatocellular carcinoma by radioembolization using 90-yttrium resin microspheres: a single center experience","volume":"11","author":"Tabone","year":"2020","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.jvir.2024.10.021_bib22","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ejso.2012.02.189","article-title":"Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma","volume":"38","author":"I\u00f1arrairaegui","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jvir.2024.10.021_bib23","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.26191","article-title":"Prognostic factors and prevention of radioembolization-induced liver disease","volume":"57","author":"Gil-Alzugaray","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2024.10.021_bib24","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.jvir.2013.07.026","article-title":"Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience","volume":"24","author":"Tohme","year":"2013","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.10.021_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.12659\/AOT.902595","article-title":"Long-term outcome after liver transplantation for hepatocellular carcinoma following yttrium-90 radioembolization bridging treatment","volume":"22","author":"Radunz","year":"2017","journal-title":"Ann Transplant"},{"key":"10.1016\/j.jvir.2024.10.021_bib26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvir.2024.10.021_bib27","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1245\/s10434-017-5950-z","article-title":"The Post-SIR-Spheres Surgery Study (P4S): retrospective analysis of safety following hepatic resection or transplantation in patients previously treated with selective internal radiation therapy with yttrium-90 resin microspheres","volume":"24","author":"Pardo","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jvir.2024.10.021_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9926704","article-title":"Predictors of successful yttrium-90 radioembolization bridging or downstaging in patients with hepatocellular carcinoma","volume":"2021","author":"Villalobos","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.jvir.2024.10.021_bib29","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/hep.29691","article-title":"Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience","volume":"68","author":"Salem","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2024.10.021_bib30","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","article-title":"A\u00a0comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization","volume":"9","author":"Lewandowski","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jvir.2024.10.021_bib31","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3390\/cancers14030630","article-title":"External validation of the RETREAT score for prediction of hepatocellular carcinoma recurrence after liver transplantation","volume":"14","author":"van Hooff","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jvir.2024.10.021_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2967\/jnumed.113.126839","article-title":"The low hepatic toxicity per gray of 90Y glass microspheres is linked to their transport in the arterial tree favoring a nonuniform trapping as observed in posttherapy PET imaging","volume":"55","author":"Walrand","year":"2014","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jvir.2024.10.021_bib33","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s00270-022-03139-6","article-title":"Optimizing 90Y particle density improves outcomes after radioembolization","volume":"45","author":"Maxwell","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2024.10.021_bib34","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jvir.2023.02.030","article-title":"Yttrium-90 radiation segmentectomy of hepatocellular carcinoma: a comparative study of the effectiveness, safety, and dosimetry of glass-based versus resin-based microspheres","volume":"34","author":"Villalobos","year":"2023","journal-title":"J\u00a0Vasc Interv Radiol"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044324006808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044324006808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T11:12:16Z","timestamp":1737544336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044324006808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1051044324006808"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2024.10.021","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resin-Based Yttrium-90 Radioembolization as a Bridging or Downstaging Treatment to Liver Transplantation for Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2024.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2024","name":"copyright","label":"Copyright"}]}}